Cargando…
Ischemic Stroke in a Patient With Atrial Tachycardia, Methylenetetrahydrofolate Reductase Mutation and New-Onset Atrial Fibrillation: Is Early Initiation of Anticoagulation Therapy Indicated?
Atrial fibrillation is the most common dysrhythmia, affecting about 6 million people in the United States. Atrial fibrillation has been shown to be an independent risk factor for stroke. Atrial tachycardia are common findings on Holter monitoring in the general population and may be associated with...
Autores principales: | Eyituoyo, Harry O, Arinze, Nkechi C, Aben, Rieta N, Sogade, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449620/ https://www.ncbi.nlm.nih.gov/pubmed/32864247 http://dx.doi.org/10.7759/cureus.9420 |
Ejemplares similares
-
Feasibility study for echocardiography‐guided lead insertion for permanent cardiac implantable electronic devices
por: Sogade, Omolade O., et al.
Publicado: (2021) -
Successful Radiofrequency Ablation of Recurrent Supraventricular Tachycardia in a Patient with Complex Congenital Heart Disease
por: Arinze, Nkechi Christiana, et al.
Publicado: (2020) -
Ventricular Fibrillation 7 Years After Left Ventricular Assist Device Implantation
por: Eyituoyo, Harry O., et al.
Publicado: (2020) -
Salt as a Trigger for Atrial Tachycardia/Fibrillation
por: Goddard, Jerome, et al.
Publicado: (2022) -
Methylenetetrahydrofolate Reductase Polymorphism and Premature Coronary Artery Disease
por: Zaghloul, Ahmed, et al.
Publicado: (2019)